DOVOBET OINTMENT 50 MCG
CALCIPOTRIOL : 50 MCG BETAMETHASONE (BETAMETHASONE DIPROPIONATE) : 0.5 MG · DIN 02244126 · LEO PHARMA INC
Health Canada status: MARKETED
What is DOVOBET OINTMENT?
DOVOBET OINTMENT 50 MCG contains CALCIPOTRIOL : 50 MCG BETAMETHASONE (BETAMETHASONE DIPROPIONATE) : 0.5 MG. It is listed in the Health Canada Drug Product Database under DIN 02244126, held by LEO PHARMA INC, supplied as OINTMENT for TOPICAL administration. Health Canada currently lists it as marketed, status dated 29-Nov-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is DOVOBET OINTMENT used for?
DOVOBET (calcipotriol and betamethasone dipropionate) ointment is indicated for the topical treatment of psoriasis vulgaris for up to 4 weeks. DOVOBET should not be used on the face.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02244126 |
|---|---|
| Brand name | DOVOBET OINTMENT |
| Generic / active ingredient | CALCIPOTRIOL : 50 MCG BETAMETHASONE (BETAMETHASONE DIPROPIONATE) : 0.5 MG |
| Manufacturer | LEO PHARMA INC |
| Strength | 50 MCG |
| Dosage form | OINTMENT |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D05AX52 CALCIPOTRIOL, COMBINATIONS |
| AHFS class | 84:06.00 ; 84:92.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 29-Nov-2001 |
| Original market date | 2001-11-29 00:00:00 |
How is it stored and handled?
Store at 5 to 25 °C.
How is it supplied?
30 g, 60 g, and 120 g
What can be used instead?
Other Canadian products sharing ATC code D05AX52 CALCIPOTRIOL, COMBINATIONS. 4 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DOVOBET GEL | 0.5 MG | GEL | LEO PHARMA INC | MARKETED | DIN 02319012 |
| ENSTILAR | 0.5 MG | AEROSOL, FOAM | LEO PHARMA INC | MARKETED | DIN 02457393 |
| TARO-CALCIPOTRIOL / BETAMETHASONE GEL | 50 MCG | GEL | TARO PHARMACEUTICALS INC | MARKETED | DIN 02525178 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.